AI Science Tracker
EN

Machine learning classified multiple sclerosis and estimated disability progression from OCT and clinical data

Not stated in the abstract reviewed · 26 Feb 2022 · medicine

Discovery

Machine learning classified multiple sclerosis and estimated disability progression from OCT and clinical data

Source check: Source checked. Not independent scientific confirmation.

Finding: The study compared classifiers for multiple-sclerosis diagnosis using OCT measurements from 72 patients and 30 healthy controls, and separately modeled disability progression from patient records using EDSS outcomes. Results are retrospective and sample-limited.

Technology: Multiple machine-learning classifiers applied to OCT measurements and longitudinal clinical records.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Multiple machine-learning classifiers applied to OCT measurements and longitudinal clinical records.
Test and result
Diagnostic evaluation included 72 patients with MS and 30 controls; progression prediction used clinical records and EDSS reference outcomes.
Limitation / still unknown
Retrospective, modest-sized cohorts; no prospective utility or deployment benefit demonstrated.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://doi.org/10.1007/s10439-022-02930-3

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.